Investment in Jiaxing Pharmaceutical Factory and Acquisition of Singapore Assets Totaling 17 Billion Yuan
April 9, 2026An innovative pharmaceutical company from Jiaxing expands its overseas presence. On April 8, the Chairman of Yunding Xinyao, Wu Yifang, announced the intended acquisition of a Singaporean company with a total transaction price of approximately 1.7 billion RMB.…
Original URL: Click here to visit original article